Genmab’s epcoritamab therapy delivers promising results for relapsed follicular lymphoma

Relapsed or refractory follicular lymphoma (FL) remains a persistent challenge for patients, particularly those with high-risk features. Genmab A/S, alongside its development partner AbbVie, announced ... Read More